Healthcare - Biotechnology - NASDAQ - US
$ 0.5655
-9.14 %
$ 21.6 M
Market Cap
-0.32
P/E
INCOME STATEMENT
7.88 M
REVENUE
-76.2 M
OPERATING INCOME
-69.2 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Bolt Biotherapeutics, Inc.
| Revenue | 7.88 M |
| Cost Of Revenue | 61.5 M |
| Gross Profit | -53.7 M |
| Operating Expenses | 84.1 M |
| Operating Income | -76.2 M |
| Other Expenses | -7 M |
| Net Income | -69.2 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| REVENUE | ||||||
| Revenue | 7.9 | 5.7 | 1.3 | 0.2 | 0.2 | 0 |
| GROSS PROFIT | ||||||
| Cost Of Revenue | 61.5 | 4.9 | 3.7 | 40.4 | 26.0 | 0.3 |
| Gross Profit | (53.7) | 0.8 | (2.4) | (40.1) | (25.8) | (0.3) |
| OPERATING INCOME | ||||||
| Operating Expenses | 84.1 | 96.0 | 94.0 | 49.4 | 31.2 | 11.6 |
| Selling, General and Administrative Expenses | 22.5 | 22.9 | 18.4 | 9.1 | 5.2 | 2.2 |
| Research and Development Expenses | 61.5 | 73.1 | 75.7 | 40.4 | 26.0 | 9.4 |
| Operating Income | (76.2) | (90.3) | (92.8) | (49.2) | (31.0) | (11.6) |
| PRE-TAX INCOME | ||||||
| Interest Income Expense | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income | 7.0 | 2.2 | (5.8) | (11.5) | 0.5 | 40 K |
| Pre-Tax Income | (69.2) | (88.1) | (98.6) | (60.7) | (30.5) | (11.6) |
| NET INCOME | ||||||
| Tax Provision | 0 | (2.2) | 5.8 | 11.5 | (0.5) | 40 K |
| Net Income | (69.2) | (85.9) | (104.4) | (72.3) | (30.0) | (11.6) |
| EPS | 1.83 | 2.3 | 2.79 | 1.99 | 0.85 | 1.23 |